Inpatient pharmacy experience with an audit for a risk evaluation and mitigation strategy for riociguat

Am J Health Syst Pharm. 2017 Nov 1;74(21):1762-1763. doi: 10.2146/ajhp170313.
No abstract available

Keywords: audit; inpatient pharmacy; riociguat; risk evaluation and mitigation strategy.

Publication types

  • Letter

MeSH terms

  • Humans
  • Inpatients
  • Medical Audit*
  • Pharmacy Service, Hospital / organization & administration
  • Pyrazoles / administration & dosage*
  • Pyrazoles / therapeutic use*
  • Pyrimidines / administration & dosage*
  • Pyrimidines / therapeutic use*
  • Risk Evaluation and Mitigation*
  • United States
  • United States Food and Drug Administration

Substances

  • Pyrazoles
  • Pyrimidines
  • riociguat